Live feed
Filing
SC 13D
SC 13D0000905718-21-000728·Abingworth LLP
Schedule 13D ownership disclosure
Vera Therapeutics Inc
Security class unavailable · CUSIP: 92337R101
Event date: 2021-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,960,231
- Percent of class
- 14.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-21-000728
- Form type
- SC 13D
- Filer
- Abingworth LLP
- CIK
- CIK 1397144
- Filed
- May 24, 2021
- Reporting period
- May 18, 2021
- Description
- Schedule 13D beneficial ownership